A hypercoagulable and hypofibrinolytic status has been described in patients 4 months after acute COVID-19, associated with persistent increased levels of D-dimer, factor VIII, plasminogen activator inhibitor-1 (PAI-1) and von Willebrand factor (vWF), markers of endothelial activation. The gene discussed is VWF; the disease is COVID-19.